Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy
Pereira, Vanessa Goncalves
Martins, Ana Maria
Is part ofClinica Chimica Acta
MetadataShow full item record
Background: Mucopolysaccharidosis type I (NIPS 1) patients present a wide range of clinical manifestations, which could be due to the high molecular heterogeneity of the IDUA gene and to pathological events besides the enzyme deficiency. the aim of this study was to identify the most common MPS I causing mutations and to evaluate some oxidative stress markers in Brazilian patients.Methods: 3 common mutations in the IDUA gene were searched in 11 MPS I patients by PCR-RFLP. Activities of antioxidant enzymes catalase and superoxide dismutase, and levels of total glutathione and thiobarbituric acid reactive substances were evaluated by spectrophotometric and colorimetric methods, during different periods of enzyme replacement therapy.Results: the most common mutations were P533R and W402X, with allelic frequencies of 33.33% and 27.8% respectively. MPS I patients presented high levels of lipid peroxidation and enzyme replacement therapy led to an increase of catalase and a decrease of superoxide dismutase activities.Conclusions: P533R and W402X accounted for more than 60% of the alleles, but no genotype-phenotype correlation could be established. the alterations in antioxidant enzyme activities suggest that oxidative stress may be an important event among MPS I patients, which could contribute to the physiopathology of the disease. (c) 2007 Elsevier B.V. All rights reserved.
CitationClinica Chimica Acta. Amsterdam: Elsevier B.V., v. 387, n. 1-2, p. 75-79, 2008.
Keywordsmucopolysaccharidosis type I
enzyme replacement therapy
- EPM - Artigos